These early studies were the first to indicate the importance of PD-L1 as a marker of efficacy in esophagogastric cancers, and that PD-L1 CPS was a better scoring system to use in adenocarcinoma histologies, whereas the tumor proportion score (TPS) was satisfactory for squamous carcinomas. This evidence concerns the gene CD274 and neoplasm.